NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation

MLA

Koch, Sina, et al. NRP1 Presented in Trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1235196696&authtype=sso&custid=ns315887.

APA

Koch, S., van Meeteren, L. A., Morin, E., Testini, C., Weström, S., Björkelund, H., Le Jan, S., Adler, J., Berger, P., & Claesson-Welsh, L. (2014). NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation.

Chicago

Koch, Sina, Laurens A. van Meeteren, Eric Morin, Chiara Testini, Simone Weström, Hanna Björkelund, Sebastien Le Jan, Jeremy Adler, Philipp Berger, and Lena Claesson-Welsh. 2014. “NRP1 Presented in Trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1235196696&authtype=sso&custid=ns315887.